-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation